Your browser doesn't support javascript.
loading
Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease.
Carugno, Andrea; Brigenti, Noemi; Gisondi, Paolo; Al Ghadban, Zeina; Parietti, Michele; Vezzoli, Pamela; Sena, Paolo; Pisciotta, Chiara.
Afiliación
  • Carugno A; Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Brigenti N; Ph.D. Program in Molecular and Translational Medicine (DIMET), University of Milan-Bicocca, Milan, Italy.
  • Gisondi P; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
  • Al Ghadban Z; Department of Medicine, Section of Dermatology and Venereology, University of Verona, Verona, Italy.
  • Parietti M; School of Medicine and Surgery (SMS), University of Milan-Bicocca, Milan, Italy.
  • Vezzoli P; Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Sena P; Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Pisciotta C; Dermatology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy.
Australas J Dermatol ; 64(4): e376-e378, 2023 11.
Article en En | MEDLINE | ID: mdl-37698028
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psoriasis / Enfermedad de Charcot-Marie-Tooth Límite: Humans Idioma: En Revista: Australas J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psoriasis / Enfermedad de Charcot-Marie-Tooth Límite: Humans Idioma: En Revista: Australas J Dermatol Año: 2023 Tipo del documento: Article País de afiliación: Italia